Jobs / United States / Astrazeneca Pharmaceuticals Lp
Director, Statistical Programming
Astrazeneca Pharmaceuticals Lp · 🇺🇸 US - Waltham - MA
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles1 certified filing for “Statistical Programming Associate Director” (Statisticians) in NC: $159k–$159k, median $159k. Most were filed at wage level II (100%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Astrazeneca Pharmaceuticals Lp
The US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Astrazeneca Pharmaceuticals Lp →
About the role
Are you an experienced Manager and Leader in Statistical Programm ing with a deep knowledge of clinical drug development and line management experience ? Would you like to be part of a fast-paced and agile global team that has a direct strategic impact on drug development, empowered and trusted to innovate and experiment? Join us at AstraZeneca Oncology Biometrics to impact a wide range of engaging projects striving to make a difference for millions of patients. Our Biometrics team consists of Statisticians, Programmer s and Information Scientists . We drive and contribute to optimized clinical drug development programs and access to information and scientific knowledge management. We are now offering an exciting opportunity for a dedicated and highly motivated individual to join us in the role as Statistical Programming Director, providing strategic programming leadership and line management within Onc Biometrics and collaborating with global product development teams . Accountabilities: This position will work in the Early Oncology Programming group and will be accountable for a large and diverse portfolio of products that cover phase 1 / 2 trials in various mechanisms of action and covering multiple indications within oncology . You will be responsible for managing and mentoring a group of programmers who are in turn accountable for efficient delivery on studies that are both outsourced and delivered internally, ensuring high-quality of deliverables while complying with AZ and industry standards, SOPs and GxP requirements. You will also be part of the larger programming leadership team within oncology programming, and responsible for various activities beyond clinical trials, such as proving strategic or SME contributions on cross-functional teams to deliver continuous improvement, innovation, and automation solutions. Essential Skills/Experience: • Minimum bachelor's degree in mathematics ( e.g., Applied Math, Engineering, etc ), Statistics, Computer Science, Life Science , Public Health or equivalent experience • Minimum 10 years of experience with advanced knowledge of the clinical development process and industry standards • 7+ year s people and or project management experience • Advanced SAS programming skills in a clinical and statistical data environment • Demonstrated programming leadership capability with ability to develop teams and individuals and lead them towards a common goal • Demonstrated influencing, planning and organizational skills • Ability to provide input to functional strategies • Strong project management skills and experience with scope management, resource management, financial management , project planning and resource allocation • Significant experience in leadership capacity with a focus on identifying , leading, and advancing talent. • Experience working in a clinical development organization with a heavy emphasis on support of multiple, ongoing projects • Thorough understanding of pharmaceutical clinical development ( i.e. understanding of statistical concepts, techniques, and clinical trial principles) and ability to manage and lead regulatory submissions. • Thorough understanding of industry standards such as CDISC and 21CFR Part 11. • Strong ability to solve problems, recommend process improvements, and execute process improvements. • Ability to lead and influence teams • Excellent verbal and written communication skills in a global environment. • Proven ability to work with cross functional teams, specifically Data Management, Biostatistics, Epidemiology, Clinical Operations, and Pha